South Africa’s HIV response could face significant pressure after the United States confirmed plans to gradually scale back funding provided through the President’s Emergency Plan for AIDS Relief (PEPFAR), one of the country’s most important international health support programmes.
The announcement has prompted concern from global health officials, who warn that a rapid withdrawal of funding could undermine years of progress in the fight against HIV/AIDS and place vulnerable communities at greater risk.
The decision also comes amid growing political tensions between Washington and Pretoria over a range of policy disagreements.
Funding withdrawal linked to broader policy disputes
In a statement, the US State Department confirmed that it had decided to begin a phased drawdown of PEPFAR activities in South Africa.
According to Washington, the move follows what it described as South Africa’s failure to make meaningful progress on several policy issues raised by the Trump administration.
Reports from US media indicate that concerns include South Africa’s relationship with Iran, its Black Economic Empowerment policies, debates surrounding the “Kill the Boer” chant and broader questions regarding political alignment.
Earlier this year, US Ambassador Leo Brent Bozell publicly outlined several policy expectations from South Africa, including stronger action against rural violence, condemnation of inflammatory political rhetoric, revisions to expropriation policies, reforms to empowerment regulations and a more neutral foreign policy position.
The United States maintains that PEPFAR was never intended to be a permanent source of funding and argues that South Africa, as an upper-middle-income economy, should increasingly finance its own healthcare programmes.
The latest development marks another chapter in increasingly strained diplomatic relations between the two countries.
Health experts warn of consequences for HIV response
UNAIDS Executive Director Winnie Byanyima urged the United States to reconsider its position, describing the funding withdrawal as a potentially serious setback for public health efforts.
South Africa is home to an estimated eight million people living with HIV, the largest HIV-positive population in the world. While the government largely funds antiretroviral medication programmes, PEPFAR has historically contributed more than $400 million annually and supported the salaries of approximately 15,000 healthcare workers.
Byanyima said the programme has played a vital role in strengthening community healthcare systems and maintaining access to testing, treatment and prevention services.
She warned that reducing support without a carefully managed transition could disrupt services and increase the risk of new infections.
The concerns extend beyond South Africa. UNAIDS has reported a broader decline in international development assistance from traditional donor countries across North America and Europe.
Global data show that approximately 32.1 million of the estimated 40 million people living with HIV are currently receiving treatment. However, around nine million people remain without access to life-saving care, while an estimated 1.2 million new infections were recorded last year.
According to Byanyima, early indicators already suggest that funding reductions are affecting HIV programmes in several countries. HIV testing rates have reportedly declined by more than 20% in some high-burden regions, while condom distribution has dropped sharply in certain areas.
Health experts fear that if these trends continue, decades of progress towards ending AIDS as a public health threat by 2030 could be placed at risk.
As discussions continue between South Africa and the United States, the future of one of the world’s largest HIV treatment and prevention programmes remains uncertain.
Source: Reuters, UNAIDS, US State Department